(Q24299670)

Hypoxia inducible factor 1 subunit alpha

1 reference

E1A binding protein p300

1 reference

Endothelial PAS domain protein 1

1 reference

histone acetyltransferase binding

1 reference

E1A binding protein p300

1 reference

Andrew L Kung

1

0 references

author name string

Sonya D Zabludoff

2

0 references

Dennis S France

3

0 references

Steven J Freedman

4

0 references

Elizabeth A Tanner

5

0 references

Annelisa Vieira

6

0 references

Susan Cornell-Kennon

7

0 references

Jennifer Lee

8

0 references

Beqing Wang

9

0 references

Jamin Wang

10

0 references

Klaus Memmert

11

0 references

Hans-Ulrich Naegeli

12

0 references

Frank Petersen

13

0 references

Michael J Eck

14

0 references

Kenneth W Bair

15

0 references

Alexander W Wood

16

0 references

David M Livingston

17

0 references

language of work or name

English

0 references

publication date

July 2004

0 references

number of pages

11

1 reference

Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity

inferred from page(s)

published in

Cancer Cell

0 references

volume

6

0 references

page(s)

33-43

0 references

issue

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Signal transduction to hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Biological consequences of tumor hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Antagonists of protein-protein interactions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

The structure of chetomin

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Immunomodulatory constituents from an Ascomycete, Chaetomium seminudum

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Suppression of tumor growth through disruption of hypoxia-inducible transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Transcription factors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Noninvasive quantitative imaging of protein-protein interactions in living subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

An essential role for p300/CBP in the cellular response to hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Molecular mechanism of hypoxia-inducible factor 1alpha -p300 interaction. A leucine-rich interface regulated by a single cysteine

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Small molecule modulators of histone acetyltransferase p300.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Hypoxia-inducible factor and its biomedical relevance

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Pharmacological rescue of mutant p53 conformation and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Ovine ill-thrift in Nova Scotia. 5. The production and toxicology of chetomin, a metabolite of Chaetomium spp

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Mycotoxin production by Chaetomium spp. and related fungi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021

Tumor microenvironment and the response to anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2004.06.009

7 January 2021